Aarti Drugs Limited — Others, 06-03-2025: Action(s) taken or orders passed

Aarti Drugs has announced a board meeting regarding the receipt of an Administrative Warning letter from SEBI related to insider trading regulations. The letter highlights lapses in obtaining requisite details about the immediate relatives of designated persons and the applicability of the company's Code of Conduct on Prohibition of Insider Trading. While the company states there is no quantified financial or operational impact, this development could raise concerns among investors about governance and compliance practices. Maintaining transparency and ensuring adherence to regulations will be crucial to bolster investor confidence.